Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I examine a rather pointed remark that Sam ...
Ozempic, Mounjaro, and other glucagon-like peptide-1 medications, otherwise known as GLP-1s, are changing how Americans shop for groceries. In early January, Food & Wine published a story about how ...
In mid-April, OpenAI launched a powerful new AI model, GPT-4.1, which it claimed “excelled” at following instructions. But the results of several independent tests suggest the model is less aligned — ...
People who take GLP-1 drugs are spending less money on food, according to a new study Charna Flam is a writer-reporter at PEOPLE. She has been working at PEOPLE since 2023. Her work has previously ...
Patients taking glucagon-like peptide 1 (GLP-1) receptor agonists for obesity appear to be discontinuing the medications before they can have any meaningful impact on weight loss, according to two new ...
The producer price index, a measure of wholesale inflation, increased 0.1% on the month, less than 0.2% forecast. PPI excluding food and energy was flat. On a year-over-year basis, headline PPI rose 2 ...
As recently as 2021, almost half of all U.S. mansions — homes with at least 5,000 square feet of livable space — cost $1 million or less. But today, only a handful of cities still offer top-end homes ...
PeaceHealth is laying off less than 1% of its systemwide workforce, affecting various roles including leadership. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results